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PLoS Neglected Tropical Diseases focuses its
scope on the ‘‘neglected’’ communicable
diseases of developing countries, diseases
that do not receive attention from the
developed world. The list of neglected
tropical diseases (NTDs) is mainly com-
prised of helminths, protozoa, and many
tropical bacterial species that currently do
not receive sufficient priority in interna-
tional public health programs and re-
search agendas. In a practical sense, these
very prevalent diseases of underdevelop-
ment are seen as neglected because they
are outside the purview of the Global
Fund and its related programs, which
concentrate only on HIV, tuberculosis
(TB), and malaria. Their neglect occurs
despite the fact that NTDs provide an
equal share of the global burden of
disease, both in terms of chronic disability
and mortality. The developed countries’
nearly exclusive interest in HIV, TB, and
malaria frames the NTD problem, and
programs focused only on the ‘‘big three’’,
in many respects, define the neglect of
other tropical diseases.
As interest in the NTDs spreads,
however, it is important to re-examine
the scope of diseases that should be
included under the term ‘‘neglected trop-
ical disease’’. In this Viewpoint article, my
premise is that the ‘‘neglected tropical
viruses’’, in particular the arthropod-borne
or arboviruses, are a disease group that
deserves to be considered among the
NTDs. Recently, the World Health Orga-
nization added dengue virus as the first
arbovirus to its list of NTDs. Because of
their link to poverty in the developing
world, I believe there are other arboviruses
that should also follow suit.
Historically, arboviruses have been most
extensively studied by researchers in
developed countries. As a result, we know
a great deal about their molecular biology,
their pathogenesis, and their potential to
re-emerge as threats to the developed
world. At first glance, arboviruses would
seem to be already well represented in the
international research agenda, particularly
under the rubric of emerging/re-emerging
diseases or biodefense pathogens. Howev-
er, several aspects of arboviral infection
and disease consequence have been ne-
glected. Arboviruses affect the impover-
ished more severely and promote poverty
in endemic regions by causing long-lasting
sequelae and devastating impacts on
quality of life. If NTDs are defined as a
group of infectious tropical diseases in
developing countries that are both poverty-
promoting and long-lasting in their health
impact, then arboviruses certainly qualify
as NTDs.
Tropical arboviral infections, like other
NTDs, occur in poor urban and rural
environments and disproportionately af-
fect low-income populations. As an exam-
ple, Rift Valley fever virus (RVFV) is
embedded in the ecosystems of many poor
African nations, but during outbreaks it
disproportionately attacks the personal
health and family incomes of semi-nomad-
ic pastoralists [1]. This vulnerable group is
at risk for RVFV because resource-limited
conditions lead to high-risk animal hus-
bandry practices and lifestyle. Other
neglected viral infections, such as Japanese
encephalitis, dengue, and chikungunya,
afflict the poor more frequently and more
severely. Arboviral disease outcomes can
contribute to poverty, perpetuating a
vicious cycle of disease, poverty, and
health care injustice.
The recent severe outbreaks of chikun-
gunya virus in India and Africa demon-
strate the propensity for arboviral infec-
tions to target the poor and exacerbate the
problems of poverty. A study of the 2005–
2006 chikungunya virus outbreak in India
suggested that poor people were more
commonly affected and that loss of income
while ill led to worsening poverty [2].
Although indicators of poverty are rarely
tracked in seroepidemiologic studies of
arboviral outbreaks, poor housing and
living conditions are usually blamed for
disease occurrence [3].
Poverty is an important determinant of
arboviral infections, and even within
wealthy industrialized nations, foci of
arboviral transmission arise in pockets of
poverty. For example, in the border
counties of Texas where dengue virus
infection is common, recent or remote
dengue infection has been associated with
very low family income (less than
US$100/week) [4]. In this fashion, tropi-
cal climate and poverty nearly guarantee
continued arboviral outbreaks and disease,
with disease transmission ecology ignoring
political, but not socioeconomic, bound-
aries.
Poverty is not sufficient, by itself, to
promote arboviral outbreaks; however, a
community’s inability to provide adequate
vector control can perpetuate the spread
of these diseases. Just as a multi-drug
administration can control many of the
parasitic NTDs, integrated mosquito con-
trol can prevent many of the neglected
tropical viral diseases. Unfortunately,
those who are impoverished are not able
to obtain either the necessary drug ther-
apies or the needed mosquito control, so
the NTDs continue to afflict millions of
people worldwide. It should be noted that
treated bednets, which have proven most
effective against malaria transmission, are
most active against biting Anopheles spp.
mosquitoes, which live peridomestically
and feed at night. Most mosquitoes
carrying arboviruses are not anopheline
species. These types of mosquito can feed
during the day or at dusk, both outdoors
and indoors, meaning that bednets will not
be a panacea for all mosquito-borne
diseases.
Too often, the environmental condi-
tions around urban slums result in perfect
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support endemic mosquito cycling of
disease [5,6]. Aedes aegypti, the primary
vector of many important arboviral dis-
eases, such as yellow fever, dengue, and
chikungunya, has been difficult to eradi-
cate and is responsible for the resurgence
of many of these diseases [7]. Infections
that were once under control, such as
yellow fever and Japanese encephalitis, are
now capable of returning with a ven-
geance to poor neighborhoods in both
wealthy and impoverished nations [8,9].
The current outbreaks of yellow fever in
Paraguay and Brazil demonstrate our
inability to control the resurgence of these
arboviral diseases [10–12]. Practices to
escape poverty are also to blame: the
spread of yellow fever in Africa and its
reemergence in Brazil has been linked to
deforestation [13].
Access to health care is another impor-
tant issue for the neglected viral diseases.
Although many viral infections are acute
in nature and often resolve spontaneously,
poor patients come to medical care late in
the course of disease, as is often seen with
dengue infections. This late presentation
leads to worsened disease outcomes than
for patients who are financially better off
and present sooner [14].
Because viral NTDs occur more com-
monly in those who are poverty-stricken, it
can be difficult to decipher all the ways in
which the diseases contribute to poverty.
Like other NTDs, viral NTDs can lead to
debilitating chronic sequelae that impact
individual work productivity and family
income. RVFV, for example, can lead to
permanent visual loss or impairment,
which can have a great impact on long-
term productivity and quality of life
[15,16]. Importantly, viral NTD outbreaks
generally lead to loss of life, family
hardship, and distress. Japanese encepha-
litis is an extreme example, where case
fatality rates can be as high as 30%, with
one-third of survivors suffering severe
neurological sequelae [17]. Because epi-
demics of arboviruses often receive notice
only when they are acute and massive, the
public loses sight of ongoing transmission,
which has a significant daily impact on the
life of people living in endemic countries.
Too often these diseases are ignored
and neglected because they have not yet
impacted the lives of those living in
affluent areas. Many of these diseases are
understudied and go unnoticed until
outbreaks affect North Americans or
Europeans, as recently displayed in the
recent surge of interest in chikungunya
after outbreaks on the Indian Ocean
islands, a favorite European vacation
destination [18]. Certain populations with-
in these neglected diseases also go unno-
ticed, such as the impact chikungunya and
dengue have had on neonates and chil-
dren [19–21]. The lack of research
contributes to our simplified understand-
ing of these infections and our inability to
decipher one infection from another. For
example, the understudied Mayaro virus
may constitute a significant portion of
dengue-like illness cases in Latin America
[22].
As more emphasis is placed on defining
the true cost of the NTDs, the real-world
problem of concurrent and overlapping
infections must be re-evaluated [23].
Although the neglected tropical viral
diseases are part of poverty in tropical
nations, their full impact is likely not to be
determined in isolation, as arboviruses
constitute a part of the larger health
problem in resource-poor settings. More
research, more insight, and more discus-
sions regarding these important NTDs and
the populations that suffer from them will
be necessary to fully define the impact of
neglected tropical viruses in the regions
where they persist.
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